InSphero sets the standard for in vitro testing of novel drugs in the pharmaceutical and biotechnology industry with comprehensive solutions that provide greater confidence in decision making. Our physiologically relevant suite of 3D InSight™ Microtissues and Services increase efficiency in drug discovery and safety testing. Founded in 2009, InSphero patent-pending technologies and methods enable large-scale, reproducible production of scaffold-free 3D microtissues driven solely by cellular self-assembly. Our assay-ready and custom 3D liver, islet, and tumor models provide unrivaled biological insight into liver toxicology, metabolic disease, and oncology. We are proud to count all of the top 10 global pharmaceutical companies in our customer base.
InSphero AG is headquartered in Schlieren, Switzerland, a technology and manufacturing hub of Zurich. Our US subsidiary, InSphero Inc., and North American bioproduction facility are based in Brunswick, Maine. We are always looking for energetic and driven personalities – people who assume responsibility, make decisions, and want to grow with our rapidly developing company. If you want to join our team, please send your application by e-mail.